Skip to Content

Join the 'Melanoma' group to help and get support from people like you.

Melanoma News

Related terms: Cancer, Melanoma, Malignant Melanoma, Skin Cancer, Melanoma

Worldwide Cancer Rates Up More Than One-Third in Past Decade: Report

Posted 6 hours ago by Drugs.com

SATURDAY, Dec. 3, 2016 – Cancer cases rose 33 percent worldwide in the past 10 years, a new study shows. In 2015, there were 17.5 million diagnoses and 8.7 million deaths in the world from the disease, the researchers found. The rise in cancer cases was mainly due to population aging and growth, along with changes in age-specific cancer rates, according to the Global Burden of Disease Cancer Collaboration study. The lifetime risk of developing cancer was one in three for men and one in four for women, the researchers said. Prostate cancer was the most common type of cancer in men (1.6 million cases), and tracheal, bronchus and lung cancer was the leading cause of cancer death in men. Breast cancer was the most common cancer for women (2.4 million cases), and the leading cause of cancer death in women. The most common cancers in children were leukemia, other neoplasms, non-Hodgkin ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Lymphoma, Melanoma, Skin Cancer, Ovarian Cancer, Cervical Cancer, Head and Neck Cancer, Testicular Cancer, Salivary Gland Cancer, Solid Tumors

Could White Wine Boost Your Melanoma Risk?

Posted 3 days ago by Drugs.com

THURSDAY, Dec. 1, 2016 – A new study raises the possibility that people who enjoy a glass of white wine every day may face a slightly elevated risk of melanoma. Total alcohol intake was associated with a 14 percent higher risk of melanoma per drink per day, researchers found. But, when they looked at the type of alcohol consumed, white wine emerged as the potential culprit. Each drink per day of white wine was associated with a 13 percent higher risk of melanoma, the researchers said. "Per drink" risk was based on 12.8 grams of alcohol – the median amount of alcohol in a beer, a glass of wine or a shot of spirits. Beer, red wine and liquor did not significantly affect melanoma risk, the study authors added. The study does not prove that white wine causes this deadly skin cancer. It merely shows an association, though one worth exploring, the researchers said. "We are just adding one ... Read more

Related support groups: Cancer, Breast Cancer, Alcohol Dependence, Colorectal Cancer, Basal Cell Carcinoma, Melanoma, Skin Cancer, Alcoholism, Hangover, Melanoma - Metastatic, Squamous Cell Carcinoma, Breast Cancer, Prevention, Head and Neck Cancer, Acute Alcohol Intoxication, History - Skin Cancer

8 of 10 Texas Salons Heed Ban on Indoor Tanning for Minors

Posted 9 days ago by Drugs.com

FRIDAY, Nov. 25, 2016 – Most indoor tanning salons in Texas comply with a law banning customers younger than 18, a new study found. Females posing as 17-year-olds called 829 tanning businesses statewide. Workers at 81 percent of the salons told the caller they could not use indoor tanning if they were 17, even with a parent's permission. "This level of compliance with the under-18 ban enacted by the Texas Legislature in 2013 underscores the importance of this approach as a strategy for skin cancer prevention," study lead author Mary Tripp said. Tripp is an instructor in behavioral science at the University of Texas MD Anderson Cancer Center. Despite high compliance with the under-18 ban, 83 percent of salons said clients could tan every day, Tripp noted in a university news release. The U.S. Food and Drug Administration recommends no more than three sessions during the first week of ... Read more

Related support groups: Basal Cell Carcinoma, Sunburn, Melanoma, Skin Cancer, Melanoma - Metastatic, Squamous Cell Carcinoma, History - Skin Cancer, Prevention of Sunburn

Can Protein in Common Skin Bacteria Offer Disease Protection?

Posted 11 days ago by Drugs.com

WEDNESDAY, Nov. 23, 2016 – Our most common skin bacteria may help shield us from some skin diseases, a new study suggests. Swedish researchers report that Propionibacterium acnes secretes a protein called RoxP that protects against bacteria that are believed to contribute to several skin disorders. Specifically, RoxP protects against skin cell damage called oxidative stress caused by reactive oxygen bacteria. UV radiation from the sun is a common cause of oxidative stress on the skin. Oxidative stress is believed to contribute to several skin diseases, including eczema, psoriasis and skin cancer. The protective effect of RoxP is as strong as antioxidants such as vitamins C and E, according to the study published recently in the journal Scientific Reports. "This protein is important for the bacterium's very survival on our skin. The bacterium improves its living environment by secreting ... Read more

Related support groups: Acne, Psoriasis, Eczema, Dermatitis, Rosacea, Contact Dermatitis, Basal Cell Carcinoma, Melanoma, Skin Cancer, Atopic Dermatitis, Melanoma - Metastatic, Squamous Cell Carcinoma, History - Skin Cancer, Minor Skin Irritation, Minor Skin Conditions

'Tailoring' Skin Exams May Boost Melanoma Detection

Posted 10 Nov 2016 by Drugs.com

THURSDAY, Nov. 10, 2016 – Some people at high risk of melanoma may benefit from more "tailored" skin exams, a new study suggests. Melanoma is the least common, but most serious form of skin cancer. It's estimated that about 76,400 Americans will be diagnosed with the disease in 2016, according to the American Cancer Society (ACS). Melanoma can be caught early if suspicious growths on the skin are detected. The new study, researchers said, helps zero in on some groups who may need to start skin exams at a younger age, or do them more often: People with a personal or family history of melanoma; and those with a lot of moles on their skin. The report also gives an idea of which body areas people should monitor with particular attention, according to lead researcher Caroline Watts. She's a research fellow at the Sydney School of Public Health, at the University of Sydney in Australia. But ... Read more

Related support groups: Basal Cell Carcinoma, Melanoma, Skin Cancer, Melanoma - Metastatic, History - Skin Cancer

Powerful Cancer Drugs Linked to Rare Heart Risks

Posted 3 Nov 2016 by Drugs.com

THURSDAY, Nov. 3, 2016 – In rare cases, potent drugs that prompt the immune system to fight cancer may threaten the heart in the process, researchers report. Known as immunotherapy, these medications have transformed cancer treatment in recent years, sending some patients who had few options left into remission. But a report in the Nov. 3 issue of New England Journal of Medicine describes two cases where patients with advanced melanoma died of heart trouble two weeks after receiving their first doses of Opdivo (nivolumab) and Yervoy (ipilimumab). One patient was a 65-year-old woman who died following a rapid heartbeat and organ failure, while the other patient was a 63-year-old man who died after two rounds of sudden cardiac arrest. With a heart attack, blood flow to the heart is blocked and tissue damage occurs, while in the case of sudden cardiac arrest the heart suddenly stops ... Read more

Related support groups: Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Melanoma - Metastatic, Opdivo, Keytruda, Tecentriq, Yervoy, Nivolumab, Pembrolizumab, Lemtrada, Campath, Alemtuzumab, Ipilimumab, Atezolizumab

Gene Test May ID Chemo Patients at Risk of Clots: Study

Posted 1 Nov 2016 by Drugs.com

TUESDAY, Nov. 1, 2016 – Genetic testing could help identify breast cancer patients at high risk for the formation of blood clots in their veins, new research suggests. This problem, called venous thromboembolism (VTE), is a serious and potentially fatal complication that can occur during cancer treatment, particularly chemotherapy. Because breast cancer is one of the most common cancers, breast cancer patients account for a large number of cancer-related VTE cases, said study author Judith Brand. She's a postdoctoral researcher in the department of medical epidemiology and biostatistics at Karolinska Institute in Stockholm, Sweden. Venous thromboembolism is preventable through treatment with an anti-clotting drug. But side effects, such as bleeding, mean this therapy is not routinely used in patients undergoing chemotherapy, the researchers explained. The new study included more than ... Read more

Related support groups: Blood Disorders, Cancer, Warfarin, Coumadin, Breast Cancer, Xarelto, Prostate Cancer, Pradaxa, Lovenox, Eliquis, Colorectal Cancer, Lung Cancer, Heparin, Melanoma, Rivaroxaban, Enoxaparin, Fragmin, Apixaban, Clexane, Arixtra

High Rate of Antidepressant Use After Cancer

Posted 27 Oct 2016 by Drugs.com

WEDNESDAY, Oct. 26, 2016 – Treatment for depression and anxiety is nearly twice as common among U.S. cancer survivors as it is for those who never had the disease, a new study finds. Among more than 3,000 adult cancer survivors, 19 percent reported taking medication for anxiety, depression or both, researchers found. But when the research team looked at nearly 45,000 adults with no history of cancer, they found just one in 10 used these medications. "Overall, these findings are sobering," said lead researcher Nikki Hawkins, a behavioral scientist at the U.S. Centers for Disease Control and Prevention. "We've come a long way in treating cancer medically, but these data tell us cancer can take a serious psychological and emotional toll for many years, even after treatment is complete," she said. Hawkins said it's remarkable that nearly one in five cancer survivors is taking medications ... Read more

Related support groups: Depression, Anxiety, Generalized Anxiety Disorder, Anxiety and Stress, Cancer, Major Depressive Disorder, Social Anxiety Disorder, Breast Cancer, Prostate Cancer, Colorectal Cancer, Dysthymia, Melanoma, Breast Cancer - Adjuvant, Cervical Cancer

Indoor Tanners Aren't Taking Precautions Against Skin Cancer

Posted 12 Oct 2016 by Drugs.com

WEDNESDAY, Oct. 12, 2016 – Frequent indoor tanners don't protect themselves from the sun and are no more likely to be screened for skin cancer than those who don't tan indoors, a new study suggests. The researchers analyzed data from a 2015 federal government health survey. It included more than 10,200 white adults aged 18 to 60 with no history of skin cancer. Of those, 7 percent said they had tanned indoors within the past year; 3.6 percent had done so one to nine times, and 3.4 percent had done it 10 times or more, the findings showed. Frequent indoor tanning was associated with less use of sunscreen, sun-protective clothing and shade while outdoors, and with several sunburns in the past year. In addition, frequent indoor tanners aged 18 to 34 were more likely to rarely or never wear sun-protective clothing or to seek shade on a sunny day than those who had never used a tanning bed. ... Read more

Related support groups: Basal Cell Carcinoma, Melanoma, Skin Cancer, Melanoma - Metastatic, Squamous Cell Carcinoma, History - Skin Cancer

Organ Transplants Linked to Higher Skin Cancer Risk

Posted 21 Sep 2016 by Drugs.com

WEDNESDAY, Sept. 21, 2016 – People who have an organ transplant may be more likely to develop skin cancer, new research suggests. The finding applies to all transplant patients, even those who are nonwhite and dark-skinned, according to Dr. Christina Lee Chung, an associate professor of dermatology at Drexel University in Philadelphia, and colleagues. The researchers said the risk increases over time with ongoing exposure to medications that suppress the immune system to prevent organ rejection. Total-body skin exams should be a routine part of care after transplant surgery, the study authors advised. For the study, the researchers analyzed medical records of 413 organ transplant recipients, 63 percent of whom were not white. The investigators found 19 new skin cancers in 15 of the nonwhite patients. That group included six black patients, five Asians and four Hispanics. Among the ... Read more

Related support groups: Basal Cell Carcinoma, Renal Transplant, Melanoma, Skin Cancer, Melanoma - Metastatic, Organ Transplant - Rejection Prophylaxis, Squamous Cell Carcinoma, Organ Transplant, Kidney Transplant, Graft-versus-host disease, History - Skin Cancer, Rejection Prophylaxis

More Cancer Patients Gaining From Immune-Based Treatments

Posted 20 Sep 2016 by Drugs.com

TUESDAY, Sept. 20, 2016 – A leading cancer group says more Americans are benefiting from immunotherapy – a relatively new treatment approach that helps the immune system target and destroy cancer cells. "The promise of immunotherapy for cancer therapy has never been greater, and the opportunity to make significant progress in this critical area is real," said Dr. Nancy Davidson, president of the American Association for Cancer Research (AACR). The AACR issued the news on immunotherapy as part of its 2016 Cancer Progress Report. As the group explained, more types of cancer are being successfully treated with immunotherapy. This treatment involves adding new cancer-fighting cells to the body or adding new elements, such as antibodies and proteins, to help the immune system fight cancer. In August 2015, one class of immunotherapy drugs – called checkpoint inhibitors – was approved for ... Read more

Related support groups: Lung Cancer, Non-Small Cell Lung Cancer, Melanoma, Melanoma - Metastatic, Bladder Cancer, Opdivo, Head and Neck Cancer, Keytruda, Hodgkin's Lymphoma, Tecentriq, Nivolumab, Pembrolizumab, Atezolizumab

Injury Risk Spikes While Cancer Patients Seek Diagnosis: Study

Posted 1 Sep 2016 by Drugs.com

THURSDAY, Sept. 1, 2016 – Cancer patients face an added risk of injuries while their condition is being diagnosed, a new study says. The findings show the need for more effort to prevent both accidental and other types of injuries while patients await a diagnosis, according to the researchers. Led by Qing Shen, a postgraduate student in the department of medical epidemiology and biostatistics at Karolinska Institute in Stockholm, Sweden, researchers studied injury-related hospitalizations of cancer patients in Sweden between 1990 and 2010. The investigators focused on the 16 weeks before and after diagnosis. During that time, nearly 721,000 patients were hospitalized. These cases included 7,300 injuries from medical complications and drug treatments, and over 8,300 injuries from accidents or intentional self-harm, the study findings showed. The risk for medical-related injuries is "not ... Read more

Related support groups: Cancer, Breast Cancer, Colorectal Cancer, Basal Cell Carcinoma, Melanoma, Skin Cancer, Squamous Cell Carcinoma, Diagnosis and Investigation, History - Skin Cancer, Prevention of Fractures

Health Insurance Status May Affect Cancer Patients' Survival

Posted 8 Aug 2016 by Drugs.com

MONDAY, Aug. 8, 2016 – Two large studies suggest that surviving certain cancers in America could depend on your health insurance status. Despite improvements in cancer diagnosis and treatment, patients who were uninsured or had Medicaid coverage were more likely to suffer worse outcomes, compared with people who have other forms of health insurance, the studies found. People who were uninsured or relied on Medicaid were diagnosed at a later stage, received sub-optimal treatment and had shorter survival, the findings showed. In the case of testicular cancer, they were at greater risk of death from their disease than patients with other insurance, the researchers found. The findings, published online Aug. 8 in the journal Cancer, add to evidence linking poor outcomes and inadequate health insurance. Dr. Christopher Sweeney, a medical oncologist at the Dana-Farber Cancer Institute in ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Basal Cell Carcinoma, Brain Tumor, Melanoma, Skin Cancer, Pancreatic Cancer, Ovarian Cancer, Cervical Cancer, Melanoma - Metastatic

Health Tip: If You Have a Lot of Moles

Posted 29 Jul 2016 by Drugs.com

-- Having lots of moles may mean you're worried about skin cancer. Checking your skin often for changes and certain warning signs can help alleviate those fears. The American Academy of Dermatology recommends: Regularly inspect your skin, evaluating all of your moles. Look for any changes or unusual looking moles. See your dermatologist if any of your moles bleed, itch or change. Don't lie in the sun or use a tanning bed. Use sunscreen whenever outdoors to help prevent sunburn. See a dermatologist if you have 100 or more moles, or a significant portion of your body is covered with darker patches. Read more

Related support groups: Basal Cell Carcinoma, Sunburn, Melanoma, Skin Cancer, Sunscreen, Melanoma - Metastatic, Squamous Cell Carcinoma, Photoaging of the Skin, Dermatoheliosis, History - Skin Cancer, Prevention of Sunburn, Deeptan, Coppertone, Minor Skin Conditions

U.S. Panel Says Evidence 'Insufficient' to Recommend Skin Cancer Screenings

Posted 26 Jul 2016 by Drugs.com

TUESDAY, July 26, 2016 – There currently isn't enough scientific proof to recommend regular full-body exams for skin cancer as a means of preventing deaths from these cancers, a leading panel of U.S. preventive health experts has concluded. An updated evidence review found scant evidence on either the benefits or harms of a health care professional performing a skin exam as part of a patient's regular check-up, said Dr. David Grossman. He is vice-chairperson of the U.S. Preventive Services Task Force (USPSTF). "We don't know if taking the extra time to examine every inch of someone's skin actually does yield benefit or causes no harm," Grossman said. Despite this, people should regularly check their own bodies for signs of skin cancer, and report anything unusual to their doctor, he added. "Someone who's got a mole they're worried about because it's growing and changing colors, they're ... Read more

Related support groups: Basal Cell Carcinoma, Melanoma, Skin Cancer, Melanoma - Metastatic, Squamous Cell Carcinoma, Diagnosis and Investigation, History - Skin Cancer

Page 1 2 3 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Melanoma - Metastatic, Skin Cancer

Related Drug Support Groups

Opdivo, Temodar, PegIntron, Keytruda, interferon alfa-2b, Yervoy, nivolumab, pembrolizumab, Intron A, view more... Sylatron, Proleukin, peginterferon alfa-2b, dacarbazine, temozolomide, ipilimumab, aldesleukin, DTIC-Dome, Imlygic, talimogene laherparepvec